NCT00789672 - Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

December 31, 2009

Conditions

Amblyopia

Interventions

DRUG

levodopa/carbidopa

Oral levodopa 0.76 mg/kg tid with carbidopa 0.17 mg/kg tid (approximately 4.5 to 1 formulation)

DEVICE

patching

2 hours daily patching

DRUG

levodopa/carbidopa

Oral levodopa 0.51mg/kg tid with carbidopa 0.17 mg/kg tid (3 to 1 formulation)

Trial Locations (1)

Wilmer Eye Institute, Baltimore